Society for Pediatric Pathology Fall Meeting 2018
October 25-28, 2018 
Graduate Hotel Ann Arbor
615 E Huron St
Ann Arbor, MI 48104 

SPP Fall Meeting

Quicklinks

Click here to book your hotel

Course Outline

Fall Meeting Learning Objectives

Click here to download the registration form

  *Please note: Social Tour and Banquet are first come first served.*

Advance registration ends October 15, 2018. After this date, participants must register at the meeting in Ann Arbor. SPP accepts VISA, MasterCard, Discover and checks made payable to the Society for Pediatric Pathology, in U.S. Dollars only. The SPP registration form can be completed and sent via email to spp@kellencompany.com or by mail with full payment to the address below:   

Mail to:
Society for Pediatric Pathology 
  355 Lexington Avenue, 15th Floor
 New York, NY 10017 USA 

Payment Instructions
Registrations must include payment by check (drawn on a U.S. bank), credit card or bank transfer of funds in U.S. dollars. Wire transfers within North America will incur a $30 fee and wire transfers outside of North America will incur a $45 fee. SPP cannot accept registrations by telephone. SPP will not accept registrations without full payment.
Caution: If you submit your registration form more than once, it may result in a duplicate charge to your credit card. Send your registration using only one method of payment.

Confirmation Letters
SPP's web-based registration system acknowledges online registrations immediately via email. You will receive a confirmation/receipt to the email address provided in the registration system shortly after your registration is complete.

SPP will confirm registrations received by email and mail within 14 days of receipt via email as well. 
Note: SPP is unable to confirm registrations earlier than two weeks after the submission date if you do not provide an email address. If you do not receive confirmation after two weeks, contact spp@kellencompany.com.

Cancellation Policy
Notification of cancellation must be submitted in writing. Cancellations received before October 15, 2018, will be refunded, less a $50 cancellation fee. Substitutions are allowed at any time, but must be submitted in writing and must be of the same member status. Cancellations will be honored, but money will not be refunded after October 15, 2018.

Hotel Accommodations

Graduate Ann Arbor Hotel
615 E Huron St
Ann Arbor, MI 48104
Website: www.graduatehotels.com/ann-arbor/
Reservations: +1-800-666-8693

Use this link to reserve your room: Book your group rate for SPP 2018 Fall Meeting

Airport Transportation Information
The Graduate Ann Arbor Hotel is 26 miles west from the Detroit Metropolitan Airport (DTW). The host hotel does not provide shuttle service. Detroit Airport Car Service & Shuttles is an option to alternate transportation from the airport to the hotel upon request.  Estimated fare is $55/$65 (one way).  Estimated taxi fare is $60 (one way). 

Delta Airlines Discount
Taking advantage of this discount is easy! Just click the “Advanced Search” link on www.delta.com and enter NMRCL in the box that says “Meeting Event Code.” If your flight qualifies for a discount, it will automatically be applied to your search results. We suggest using this discount to book your SPP flight.

Parking
On-site parking is not available Valet parking only, $25 per day with in & out privileges 

Ann Arbor Climate
The average daytime high temperature in Ann Arbor, Michigan in October is 61°F (16°C); the average low temperature is 42°F (9°C). Because people have varying sensitivities to temperatures in hotel meeting rooms, please bring a sweater or other warm clothing to wear inside the hotel.

Questions? Questions regarding the annual meeting may be directed to spp@kellencompany.com or by phone +1-212-297-2196.

Perinatal Symposium
Title: Updates on Congenital Malformations
Symposium Director: Amer Heider, MD, Assistant Professor, Department of Pathology, Michigan Medicine, University of Michigan
Learning Objectives:

1. Recognize the appropriate use of genetic testing in congenital malformation cases, including the financial and technical aspects and limitations for the tests, such as sequencing.
2. Describe perinatal imaging characteristics in malformation cases and discuss the complementary nature of fetal MRI and obstetric ultrasound.
3. Identify the utility of fragmented fetal examination in congenital malformations, including the technical challenges and importance of recognizing relevant clinical information.
   

Event Hours

Registration Hours:

Poster Presentation Schedule:

Meeting Objectives
Upon completion of this meeting, learners should be able to:

• Acknowledge recent advancements in research and practice related to the biology, characterization and/or diagnosis of pediatric disease. 
• Identify areas with recent significant advancement in the practice of pediatric pathology.
• Implement diagnostic and consultative management updates in pediatric pathology into practice.
• Summarize clinicopathologic differential diagnoses and pathologic processes of perinatal and pediatric disorders and their complications, as well as their treatments and possible outcomes.

Course Outline:

Presenter's Information

• Syllabus Guidelines
• Learning Objectives Guidelines
• SAM Question Guidelines and Submission form

Abstract Submission
Please Note: Abstract Submissions are now closed
 

Continuing Medical Education Accreditation

Accreditation Statement
The Society for Pediatric Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) and The Society for Pediatric Pathology.

Accreditation and Credit Designation
This activity has been approved for 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Physicians
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit(s) ™.

Health Professionals
Health Professional participants (including residents and fellows-in-training) may claim hours to receive a Certificate of Participation for an activity designated for AMA PRA Category 1 Credit(s) ™.

Course Director
Dr. Lili Miles

Learning Objectives
As a result of this meeting, participants will be able to:

• Acknowledge recent advancements in research and practice related to the biology, characterization and/or diagnosis of pediatric disease.
• Identify areas with recent significant advancement in the practice of pediatric pathology.
• Implement diagnostic and consultative management updates in pediatric pathology into practice.
• Summarize clinicopathologic differential diagnoses and pathologic processes of perinatal and pediatric disorders and their complications, as well as their treatments and possible outcomes.

Target Audience

• Pediatric Pathologists
• Fellows-in-Training
• Residents (Pathology)
• Pediatric Gastroenterologists;
• Educational Need

Health care in the US is changing and cost is significantly increasing with more technological advances and reimbursement is shrinking. More emphases are being placed on improving quality of care, patient experience, and safety while reimbursement is shifting from volume to value. The Affordable Care Act created a number of new payment models rewarding quality and outcome rather than the traditional unit of service. Payers, patients and health care providers are struggling to understand how to adapt to these changes. In order to meet these challenges, pathologists must be prepared and identify new roles and opportunities in this changing environment. They need to partner with clinicians to increase the value of care delivery, share their expertise in selecting the optimal tests, participate in decision making and focus on transforming the patient experience. Most importantly pathologists can’t afford to stay behind the scenes. They need to be more visible in their institutions and to the public to be recognized. Pathologists need to make patients, families, administrators and legislators aware of the value they add to the overall patient care. Otherwise, these changes in reimbursement, health system structure, competency requirements and practice structure will potentially have a negative impact on our salaries and autonomy.
The ACGME in conjunction with the American Board of Pathology has also implemented training milestones in pathology. There is more emphasis on interpersonal and communication, teamwork, system based learning, Quality Improvement (QI) and Patient Safety (PS). There are limited resources available to the pathologists in general and more so to pediatric pathologists to learn about all these changes and how to participate in the new proposed value driven, safer, effective, efficient, equitable and patient centered care. Many hospitals and health systems are struggling with how to focus their leadership efforts and resources to achieve this better care lower cost model.

Medical Knowledge: New knowledge about QI tools such as root cause analysis, process mapping and improvement, transparency in addressing mistakes, appropriate laboratory utilization, decreasing waste, pathologist’s role in collaborative teams and redesigning care to be more efficient, effective and patient/family centered.

Competency need: competence in teaching and participating in quality improvement projects, understanding of value as defined by those we serve, multidisciplinary appropriate laboratory utilization, using LEAN/PDCA methods.

Performance need: Change the pathologists practice and strategies to be more visible to patients, families, clinical teams and administrators.

DISCLAIMER: These materials and all other materials provided in conjunction with continuing medical education activities are intended solely for purposes of supplementing continuing medical education programs for qualified health care professionals. Anyone using the materials assumes full responsibility and all risk for their appropriate use. The SPP makes no warranties or representations whatsoever regarding the accuracy, completeness, currentness, noninfringement, merchantability or fitness for a particular purpose of the materials. In no event will the SPP be liable to anyone for any decision made or action taken in reliance on the materials. In no event should the information in the materials be used as a substitute for professional care.

Claiming CME Credit
Certificates of continuing medical education AMA PRA Category 1 Credits™ will be issued through the Society for Pediatric Pathology. CME credits will only be awarded after completion of an online evaluation form.

SPP Spring 2019 Meeting
March 15^th - 17th, 2019 
Crystal Gateway Marriott
(within driving distance of National Harbor, MD)

Quicklinks

Click here to make your hotel reservation

Committee Meetings – March 15^th, 2019
Scientific and Educational Sessions – March 16^th, 2019 and March 17^th, 2019 Symposium: “Lymph Node Pathology for the Pediatric Pathologist”

Andrea N. Marcogliese MD, Baylor College of Medicine
M. Kamran Mirza, MD PhD, Loyola University Medical Center, Aliya N. Husain, MD, University of Chicago, Kevin E. Fisher, MD, PhD, Texas Children’s Hospital, Carl Allen MD, PhD, Texas Children's Cancer Center 

Upon completion of this educational activity, participants will be able to:

• Identify the 2016 updates to pediatric lymphomas and lymphoproliferative disorders in the WHO classification of pediatric hematologic malignancies
• Use touch preparations and review fine needle aspirate smears to accurately assess lymphoid tissue and select appropriate testing to make a diagnosis and make best use of tissue, especially when limited, and utilize a comprehensive yet cost effective approach to the diagnosis of lymphoid lesions
• Integrate molecular diagnostic data into diagnostic algorithms and appropriately order and interpret test results in the context of a diagnostic work up of lymphoma and select appropriate ancillary studies that identify potential prognostic and/or therapeutic markers relevant to lymphomas
  
  Workshop Session I
  
  A. Year 1/3: Role of Bias in Pediatric Pathology: Preventing Errors and Enhancing Patient Safety One Child at a Time. Vinay Prasad, MD, Monroe Carrell Jr. Children's Hospital at Vanderbilt, Kathleen Nicol, MD, Nationwide Children's Hospital, The Ohio State University

At the end of this presentation, participants should be able to:

• Identify different cognitive biases that can cause errors
• Participants will be able to utilize de-biasing strategies, thereby preventing errors
• Participants will understand the dual processing system that we use every day, and utilize their understanding of Type 1 (intuitive) and Type 2 (analytic) processes to avoid errors and failure.

B. Year 2/3: Bone dysplasias: A systematic diagnostic approach - Linda Ernst, MD, Northshore University Healthsystem, Evanston Hospital and Peter Nikkels, MD, University Medical Center Utrecht, Netherlands         

At the end of this presentation, participants should be able to:

• Describe the diagnostic histological aspects of some common skeletal dysplasia’s recognizable at birth.
• Describe the diagnostic features of the X-rays of several common skeletal dysplasias recognizable at birth.
• Recognize the limitations of histology to diagnose a skeletal dysplasia.
• Use a diagnostic scheme to diagnose the more common skeletal dysplasia’s recognizable at birth.

C. Year 3/3: Challenges in Pediatric Soft Tissue Pathology: A Case-Based Approach to Selected Difficult Cases- Jennifer Black, MD, University of Colorado Anschutz School of Medicine, Children’s Hospital Colorado, Aurora, Colorado and Erin R. Rudzinski, MD; Seattle Children’s Hospital, Seattle, Washington                           

At the end of this presentation, participants should be able to:

• Describe the distinguishing features and the differential diagnosis for frequently encountered pediatric soft tissue lesions and their histologic mimics.
• Select appropriate ancillary tests to confirm diagnosis, including a strategic panel of immunohistochemical stains, electron microscopy, conventional cytogenetics analysis and molecular genetic testing.
• Create a pathology report including all essential information for the diagnosis of an intermediate or malignant soft tissue lesion to facilitate further patient management.

Workshop Session II

D. Year 1/3: What Can the Placenta Tell Us? Debra S. Heller, MD, Rutgers-New Jersey Medical School, Rebecca N. Baergen, MD, Weill Cornell Medical College – New York Presbyterian Hospital

At the end of this presentation, participants should be able to:

• Diagnose placental lesions with a risk of recurrence in future pregnancies
• Diagnose placental lesions associated with neurologic injury and stillbirth
• Understand the terminology used in placental pathology including the Amsterdam Placental Workshop Guidelines
  
  E. Year 2/3: What every pediatric pathologist needs to know: WHO Classification of Tumors of the Central Nervous System (2016) Pediatric Tumors – Alexander Judkins, MD, Children's Hospital Los Angeles and Cynthia Hawkins, MD, Hospital for Sick Children, Toronto and Mariarita Santi, MD, Children's Hospital of Philadelphia             
  
  At the end of this presentation, participants should be able to:  
  Cynthia Hawkins:
  
• Apply the 2016 WHO Classification of Tumors of the Central Nervous System to the diagnosis of medulloblastoma
• Integrate morphologic and molecular results into a comprehensive pathology report for the diagnosis of medulloblastoma
• Apply immunohistochemical and molecular techniques to determine medulloblastoma molecular subgroup
• Appreciate the clinical relevance of molecular subgrouping and TP53 mutation status in medulloblastoma
  
  Alexander Judkins:
• Apply the 2016 WHO Classification of tumors of the Central Nervous System to the diagnosis of pediatric embryonal CNS tumors (non-medulloblastoma)
• Integrate morphologic and molecular results into a comprehensive pathology report for the diagnosis of pediatric embryonal CNS tumors (non-medulloblastoma).
• Distinguish AT/RT lacking histological features of rhabdoid differentiation from other pediatric CNS embryonal tumors on the basis of immunohistochemistry and/or molecular analysis of SMARCB1/INI1 and/or SMARCA4/BRG1.
• Using their molecular profile, distinguish C19MC-altered embryonal tumors from other pediatric embryonal CNS tumors.
  
  Mariarita Santi:
  
  
• Apply the 2016 WHO Classification of tumors of the Central Nervous System to the diagnosis of pediatric glial tumors
• Approach the diagnosis of pediatric glial brain tumors using a combination of morphology and molecular diagnostic techniques
• Distinguish the BRAF mutated glial tumors from the Histone-3 mutated tumors and extrapolate the prognostic implications.
• Separate the molecular profile of supratentorial ependymomas from the infratentorial
• Integrate morphologic and molecular results into a comprehensive pathology report.
  
  F. Year 3/3: Pediatric Gastrointestinal Biopsy: An Update on the Diagnosis and Pathogenesis of Pediatric Upper Gastrointestinal Disease - Amy Lowichik, MD, PhD, University of Utah School of Medicine, Salt Lake City, UT and Raul S. Gonzalez, MD, University of Rochester Medical Center, Rochester, NY                                               
  
  At the end of this presentation, participants should be able to:
• Recognize the inflammatory findings characteristic of allergic and autoimmune diseases of the pediatric upper gastrointestinal tract.
• Describe the histologic criteria for pre-malignant and malignant lesions of the pediatric upper gastrointestinal tract.
• Order and recommend appropriate ancillary testing for common and rare developmental, allergic, autoimmune, pre-malignant and malignant lesions of the pediatric upper gastrointestinal tract.
  

SAVE THE DATE

Combined SPP - PPS Meeting  
October 16-20, 2019
Pittsburgh, Pennsylvania

The Society for Pediatric Pathology is soliciting proposals for the 2020 SPP Fall Meeting host institution.

The Society holds a Fall Meeting each year at various pediatric institutions throughout North America; this Meeting includes the presentation of scientific abstracts, and a symposium that draws upon the expertise of local faculty, and a separate symposium on a perinatal topic. An informal atmosphere allows for interchange among colleagues and an opportunity to visit the institutions of peers.

If you are interested in submitting a proposal, please read the Host Responsibilities document and submit your proposal via email to Patricia Ferchland-Bingham.